Literature DB >> 19688284

Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats.

Nabil M Abdel-Hamid1.   

Abstract

Chemical composition of extracellular matrix (ECM) plays a pivotal role in cellular and tissue development, regeneration, and differentiation. It also plays a key role in pathogenesis of hepatocellular carcinoma (HCC). This study explored premalignant changes in the liver tissue content of collagen (as hydroxyproline, HP), total glycosaminoglycans (TGAGs), free glucosamine (FGA), total sialic acid (TSA), lysosomal membrane integrity variations (calculated as total and free cathepsin D activities), and liver histology. Serum alfa-fetoprotein (AFP) level was used as an early marker for HCC in two groups of Wistar rats. One group of rats served as control and was provided normal saline orally. The other group was provided trichloroacetic acid (TCA) as 0.5 g/kg/day for five consecutive days by oral gavage. Animals were killed before tumor development. The treatment revealed dysplastic changes in addition to microsteatosis (fatty changes). Both sinusoids and the portal vein among dysplastic cells were dilated and congested. These dysplastic foci are believed to be premalignant and may be precancerous lesions. The following things were observed: a highly significant increase in serum AFP (as a key marker for HCC), a significant decrease in HP and TSA, a significant increase in FGA, nonsignificant decrease in TGAGs, significant up-regulation of free cathepsin D, nonsignificant decrease in total cathepsin D activities, and destabilization of lysosomal membrane integrity. Down-regulation of HP, TSA, and TGAGs seems to be a prerequisite for cancer development. This might be stimulated by up-regulation of free cathepsin D activity. Perhaps tissue fibrosis is not a condition for developing HCC because collagen was significantly depressed. Up-regulated FGA could be assumed to be a defense mechanism against TCA-induced proteolysis of membrane proteins because it is frequently reported to be of value in cancer chemotherapy. Studied ECM perturbations can be assumed as preliminary changes during chemical hepatocarcinogenesis at the tissue level. Prospective studies on blood levels of cathepsins, TGAGs, and individual ECM variables such as TSA, FGA, and Hp in patients at risk for HCC, performed in parallel with assessments of AFP, may provide a cost-effective way to find new links between tissue changes and circulation that would permit early prediction of disease. It may also provide a way to monitor HCC and compensate for the missed peak AFP values.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688284     DOI: 10.1007/s00232-009-9196-y

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  65 in total

1.  An improved micromethod for tyrosine estimation.

Authors:  Munjal M Acharya; Surendra S Katyare
Journal:  Z Naturforsch C J Biosci       Date:  2004 Nov-Dec

2.  Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed?

Authors:  Xiong Zhi Wu; Dan Chen; Guang Ru Xie
Journal:  Med Hypotheses       Date:  2006-02-28       Impact factor: 1.538

3.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

4.  Insulin-dependent changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart.

Authors:  M A Nerurkar; J G Satav; S S Katyare
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

5.  N-[18F]fluoroacetyl-D-glucosamine: a potential agent for cancer diagnosis.

Authors:  T Fujiwara; K Kubota; T Sato; T Matsuzawa; M Tada; R Iwata; M Itoh; J Hatazawa; K Sato; H Fukuda
Journal:  J Nucl Med       Date:  1990-10       Impact factor: 10.057

6.  Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.

Authors:  B Werle; C Kraft; T T Lah; J Kos; U Schanzenbächer; K Kayser; W Ebert; E Spiess
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

7.  Collagens in the liver extracellular matrix bind hepatocyte growth factor.

Authors:  D Schuppan; M Schmid; R Somasundaram; R Ackermann; M Ruehl; T Nakamura; E O Riecken
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

8.  Is activation of lysosomal enzymes responsible for paracetamol-induced hepatotoxicity and nephrotoxicity?

Authors:  M A Khandkar; D V Parmar; M Das; S S Katyare
Journal:  J Pharm Pharmacol       Date:  1996-04       Impact factor: 3.765

9.  Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity.

Authors:  C R Elcombe; M S Rose; I S Pratt
Journal:  Toxicol Appl Pharmacol       Date:  1985-07       Impact factor: 4.219

10.  THE ESTIMATION OF PEPSIN, TRYPSIN, PAPAIN, AND CATHEPSIN WITH HEMOGLOBIN.

Authors:  M L Anson
Journal:  J Gen Physiol       Date:  1938-09-20       Impact factor: 4.086

View more
  5 in total

1.  Novel biochemical pathways for 5-Fluorouracil in managing experimental hepatocellular carcinoma in rats.

Authors:  Nabil M Abdel-Hamid; Mohamed A Morsy
Journal:  J Membr Biol       Date:  2010-02-23       Impact factor: 1.843

2.  Investigation of an Alternative Marker for Hypermutability Evaluation in Different Tumors.

Authors:  Anqi Chen; Suhua Zhang; Lei Xiong; Shihan Xi; Ruiyang Tao; Chong Chen; Jixi Li; Jinzhong Chen; Chengtao Li
Journal:  Genes (Basel)       Date:  2021-01-29       Impact factor: 4.096

3.  Functional and topological properties in hepatocellular carcinoma transcriptome.

Authors:  Ignat Drozdov; Jan Bornschein; Thomas Wex; Najl V Valeyev; Sophia Tsoka; Peter Malfertheiner
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

4.  Hepatocyte Lysosomal Membrane Stabilization by Olive Leaves against Chemically Induced Hepatocellular Neoplasia in Rats.

Authors:  N M Abdel-Hamid; M A El-Moselhy; A El-Baz
Journal:  Int J Hepatol       Date:  2010-12-05

Review 5.  Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma.

Authors:  Mohammed A Alshehri; Moath M Alshehri; Naif N Albalawi; Moshari A Al-Ghamdi; Mohammed M H Al-Gayyar
Journal:  Oncol Lett       Date:  2021-01-04       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.